BSX

Boston Scientific Corporation

$44.70

1.54%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.

Source: Yahoo Finance
AI summary

Price & performance

1M+2.1%
3M-10.2%
YTD-54.1%
1Y-55.9%
52-week range—
Beta0.53
Full chart and returns against a benchmark

Q-Score

63/ 100

Quality against peers; 50 is the peer median.

Growth51
Risk73
Performance39
Valuation70
Profitability75
Leverage58
Sentiment29
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$20.1B+19.9%
Net income$2.9B+56.7%
Net margin14.4%+3.4 pts
Historical fundamentals

Red flags in filings

1active red flag
Cybersecurity incidentSep 8, 2026
Filings, findings and the timeline

Revenue exposure

36%of revenue from outside the US
United States64%
EMEA17%
Asia Pacific15%
Regions, segments, customers and suppliers

Valuation

BSXIndustryP/E18.5529.61P/S3.083.49EV/EBITDA14.1618.38P/B2.533.39PEG0.730.73
Dividend yield0.00%
Every valuation metric

Earnings

Oct 28next report, before the open
EPS estimate$0.75
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate